share_log
Breakings ·  Dec 16, 2024 21:37
Maia Biotechnology Granted FDA Rare Pediatric Disease Designation for Thio as a Treatment for Pediatric High-Grade Gliomas
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment